Targeting of insulin-like growth factor type 1 receptor in Ewing sarcoma: Unfulfilled promise or a promising beginning? Comment uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Bone Neoplasms
  • Receptor, IGF Type 1
  • Sarcoma, Ewing

publication date

  • December 2011

Research

keywords

  • Comment

Identity

Digital Object Identifier (DOI)

  • 10.1200/JCO.2011.38.2374

PubMed ID

  • 22025158

Additional Document Info

start page

  • 4581

end page

  • 3

volume

  • 29

number

  • 34